109 related articles for article (PubMed ID: 16079931)
21. JIKEI HEART Study--a morbi-mortality and remodeling study with valsartan in Japanese patients with hypertension and cardiovascular disease.
Mochizuki S; Shimizu M; Taniguchi I; Kanae K; Yoshida S; Tajima N; Dahlöf B;
Cardiovasc Drugs Ther; 2004 Jul; 18(4):305-9. PubMed ID: 15367828
[TBL] [Abstract][Full Text] [Related]
22. Valsartan restores sarcoplasmic reticulum function with no appreciable effect on resting cardiac function in pacing-induced heart failure.
Okuda S; Yano M; Doi M; Oda T; Tokuhisa T; Kohno M; Kobayashi S; Yamamoto T; Ohkusa T; Matsuzaki M
Circulation; 2004 Feb; 109(7):911-9. PubMed ID: 14757694
[TBL] [Abstract][Full Text] [Related]
23. [Valsartan improves symptoms and quality of life in patients with chronic heart failure].
Baumhäkel M; Müller U; Böhm M
MMW Fortschr Med; 2008 Apr; 150 Suppl 1():48-53. PubMed ID: 18540333
[TBL] [Abstract][Full Text] [Related]
24. Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial.
van der Bom T; Winter MM; Bouma BJ; Groenink M; Vliegen HW; Pieper PG; van Dijk AP; Sieswerda GT; Roos-Hesselink JW; Zwinderman AH; Mulder BJ
Circulation; 2013 Jan; 127(3):322-30. PubMed ID: 23247302
[TBL] [Abstract][Full Text] [Related]
25. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction.
Solomon SD; Skali H; Anavekar NS; Bourgoun M; Barvik S; Ghali JK; Warnica JW; Khrakovskaya M; Arnold JM; Schwartz Y; Velazquez EJ; Califf RM; McMurray JV; Pfeffer MA
Circulation; 2005 Jun; 111(25):3411-9. PubMed ID: 15967846
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
27. Valsartan and the renin-angiotensin-aldosterone system: blood pressure control and beyond.
Dahlöf B
J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2 Suppl):S14-6. PubMed ID: 17199213
[TBL] [Abstract][Full Text] [Related]
28. Aliskiren in combination with valsartan exerts synergistic protective effects against ventricular remodeling after myocardial infarction in mice.
Higashikuni Y; Takaoka M; Iwata H; Tanaka K; Hirata Y; Nagai R; Sata M
Hypertens Res; 2012 Jan; 35(1):62-9. PubMed ID: 21833001
[TBL] [Abstract][Full Text] [Related]
29. Renin-angiotensin system blockade in the treatment of heart failure and the role of valsartan in this treatment.
Kılıçkıran Avcı B; İkitimur B; Karadağ B; Öngen Z
Anadolu Kardiyol Derg; 2014 Dec; 14 Suppl 2():S1-8. PubMed ID: 25604202
[TBL] [Abstract][Full Text] [Related]
30. Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure.
Kasama S; Toyama T; Sumino H; Matsumoto N; Sato Y; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
J Nucl Med; 2007 Dec; 48(12):1993-2000. PubMed ID: 18006623
[TBL] [Abstract][Full Text] [Related]
31. [Clinical study of the month. Effects of valsartan in chronic heart failure: the VAL-HeFT study].
Piérard L
Rev Med Liege; 2002 Jan; 57(1):57-9. PubMed ID: 11899501
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 4th communication: improvement of heart failure of rats with myocardial infarction by valasartan.
Hayashi N; Fujimura Y; Yamamoto S; Kometani M; Nakao K
Arzneimittelforschung; 1997 May; 47(5):625-9. PubMed ID: 9205776
[TBL] [Abstract][Full Text] [Related]
33. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
34. Molecular signaling mediated by angiotensin II type 1A receptor blockade leading to attenuation of renal dysfunction-associated heart failure.
Li Y; Takemura G; Okada H; Miyata S; Maruyama R; Esaki M; Kanamori H; Li L; Ogino A; Ohno T; Kondo T; Nakagawa M; Minatoguchi S; Fujiwara T; Fujiwara H
J Card Fail; 2007 Mar; 13(2):155-62. PubMed ID: 17395057
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin II type 1 receptor blocker, valsartan, prevented cardiac fibrosis in rat cardiomyopathy after autoimmune myocarditis.
Tachikawa H; Kodama M; Hui L; Yoshida T; Hayashi M; Abe S; Kashimura T; Kato K; Hanawa H; Watanabe K; Nakazawa M; Aizawa Y
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S105-10. PubMed ID: 12688405
[TBL] [Abstract][Full Text] [Related]
36. Mechanical dyssynchrony after myocardial infarction in patients with left ventricular dysfunction, heart failure, or both.
Shin SH; Hung CL; Uno H; Hassanein AH; Verma A; Bourgoun M; Køber L; Ghali JK; Velazquez EJ; Califf RM; Pfeffer MA; Solomon SD;
Circulation; 2010 Mar; 121(9):1096-103. PubMed ID: 20176989
[TBL] [Abstract][Full Text] [Related]
37. AT2 receptor mediates the cardioprotective effects of AT1 receptor antagonist in post-myocardial infarction remodeling.
Oishi Y; Ozono R; Yoshizumi M; Akishita M; Horiuchi M; Oshima T
Life Sci; 2006 Dec; 80(1):82-8. PubMed ID: 17023005
[TBL] [Abstract][Full Text] [Related]
38. Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
Kumar A; Aronow WS; Vadnerkar A; Sivan K; Mittal S
Am J Ther; 2009; 16(1):5-7. PubMed ID: 19142162
[TBL] [Abstract][Full Text] [Related]
39. Unraveling regulatory mechanisms of atrial remodeling of mitral regurgitation pigs by gene expression profiling analysis: role of type I angiotensin II receptor antagonist.
Chen MC; Chang JP; Chang TH; Hsu SD; Huang HD; Ho WC; Wang FS; Hsiao CC; Liu WH
Transl Res; 2015 May; 165(5):599-620. PubMed ID: 25500755
[TBL] [Abstract][Full Text] [Related]
40. Radionuclide imaging of angiotensin II type 1 receptor upregulation after myocardial ischemia-reperfusion injury.
Higuchi T; Fukushima K; Xia J; Mathews WB; Lautamäki R; Bravo PE; Javadi MS; Dannals RF; Szabo Z; Bengel FM
J Nucl Med; 2010 Dec; 51(12):1956-61. PubMed ID: 21078800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
